PIFFY yields 3.66% · PFE yields 6.13%● Live data
📍 PIFFY pulled ahead of the other in Year 1
Combined, PIFFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PIFFY + PFE for your $10,000?
PT Indofood CBP Sukses Makmur Tbk, together with its subsidiaries, produces and sells consumers products in Indonesia, rest of Asia, the Middle East, Africa, and internationally. It offers noodles, sauces, and instant seasonings under the Indomie, Supermi, Sarimi, Pop Mie, Sakura, and Mi Telur Cap 3 Ayam brands, as well as sweetened condensed milk; UHT, sterilized bottled, and pasteurized liquid milk; powdered milk; ice cream; and butter under the Indomilk, Cap Enaak, Tiga Sapi, Kremer, Orchid Butter, Indofoof Icecream, Good To Go, and Milkuat brands. The company also provides chips and non-chips snacks, such as potato-based biscuits, cassavas, and wheat flour under the Chitato, Qtela, Chiki, Jetz, Trenz, Chitato Lite, and Maxicorn brands; and food seasonings, including powdered and liquid seasonings, condiments, and syrups under the Sambal Indofood, Bumbu Special Indofood, Bumbu Racik, Indofood Freiss, and Kecap Indofood brands. In addition, it offers nutrition and special foods, such as baby cereals, follow-on cereals, noodle soups, and baby biscuits, as well as fortified milk for expectant and lactating mothers under the Promina, Sun, Govit, and Gowell brands; and beverages comprising tea, packaged water, and fruit-flavored drinks under the brands of Ichi Ocha, Club, and Fruitamin. Further, the company manufactures packaging materials and non-alcoholic beverages; markets and distributes culinary products; processes oil and fats; manages restaurants; and provides investment and trade export agency, management consulting, general trading, and transportation services. Additionally, it produces and distributes of dairy products and industrial estate. The company was founded in 1982 and is headquartered in Jakarta, Indonesia. PT Indofood CBP Sukses Makmur Tbk is a subsidiary of PT Indofood Sukses Makmur Tbk.
Full PIFFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.